Steven Cohen Ngm Biopharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $85,991 - $124,826	23,116 New	23,116 $94,000
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $12.1 Million - $16.9 Million	-957,762 Reduced 72.52%	362,900 $4.75 Million
Q2 2022 Aug 15, 2022	SELL	$10.58 - $17.5 $20 Million - $33.1 Million	-1,890,209 Reduced 58.87%	1,320,662 $16.9 Million
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $1.2 Million - $1.62 Million	-87,027 Reduced 2.64%	3,210,871 $49 Million
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $32 Million - $40.8 Million	1,854,904 Added 128.55%	3,297,898 $58.4 Million
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $11.7 Million - $15.2 Million	578,794 Added 66.97%	1,442,994 $30.3 Million
Q2 2021 Aug 16, 2021	SELL	$15.06 - $30.03 $19.7 Million - $39.4 Million	-1,310,800 Reduced 60.27%	864,200 $17 Million
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $10.3 Million - $13.2 Million	413,843 Added 23.5%	2,175,000 $63.2 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $2.42 Million - $4.69 Million	149,307 Added 9.26%	1,761,157 $53.4 Million
Q3 2020 Nov 16, 2020	BUY	$15.59 - $19.97 $1.38 Million - $1.76 Million	88,265 Added 5.79%	1,611,850 $25.6 Million
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $6.31 Million - $12.4 Million	527,290 Added 52.93%	1,523,585 $30.1 Million
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $9.96 Million - $19.4 Million	996,295 New	996,295 $12.3 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.